Literature DB >> 10320822

Different inhibitory actions of IGFBP-1, -2 and -4 on IGF-I effects in vascular smooth muscle cells.

T Gustafsson1, P Andersson, H J Arnqvist.   

Abstract

IGF-I is involved in the regulation of metabolism, growth and migration of vascular smooth muscle cells (VSMCs). We have studied how IGFBP-1, -2 and -4 modulate IGF-I-induced DNA and protein synthesis in cultured rat VSMCs. DNA and protein synthesis were measured as incorporation of [3H]thymidine and [3H]leucine into DNA and protein respectively. Western immunoblot was used to detect IGFBPs in conditioned medium and solution hybridization was used to measure IGFBP gene expression. IGF-I stimulated DNA synthesis with an EC50 of 44 pM, reaching a maximal effect at 1 nM. An IGF-I concentration of 1 nM was subsequently used in the experiments with IGFBPs. IGFBP-1 and IGFBP-4 acted in an inhibitory manner on IGF-I-induced DNA synthesis with calculated IC50 values of 1.6 nM and 6.2 nM respectively. IGFBP-2 (16 nM) also inhibited the growth response to IGF-I, but this effect could only be obtained if the two peptides were pre-incubated together for 2 h prior to addition to the cells. IGFBP-1, -2 and -4 inhibited IGF-I-induced protein synthesis in a similar way. Immunoblot of the incubation medium showed little degradation of IGFBP-2 and -4 for up to 24 h. mRNA for IGFBP-2 and -4, but not for IGFBP-1 was detected in the VSMCs. Endogenous IGFBP-2 and -4 could be detected by immunoblot in the conditioned medium but only if it was concentrated. In conclusion, IGFBP-1, -2 and -4, of which IGFBP-2 and -4 may be locally derived, act as inhibitors with different potencies on IGF-I effects in VSMCs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10320822     DOI: 10.1677/joe.0.1610245

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  4 in total

1.  Pregnancy-associated plasma protein-A regulates myoblast proliferation and differentiation through an insulin-like growth factor-dependent mechanism.

Authors:  Ashok Kumar; Subburaman Mohan; Jacqueline Newton; Mark Rehage; Kiet Tran; David J Baylink; Xuezhong Qin
Journal:  J Biol Chem       Date:  2005-08-22       Impact factor: 5.157

2.  Insulin-like growth factor (IGF) binding protein-4 is both a positive and negative regulator of IGF activity in vivo.

Authors:  Yun Ning; Alwin G P Schuller; Cheryl A Conover; John E Pintar
Journal:  Mol Endocrinol       Date:  2008-02-07

3.  IGFBP-4 regulates adult skeletal growth in a sex-specific manner.

Authors:  David E Maridas; Victoria E DeMambro; Phuong T Le; Kenichi Nagano; Roland Baron; Subburaman Mohan; Clifford J Rosen
Journal:  J Endocrinol       Date:  2017-02-09       Impact factor: 4.286

4.  Recombinant PAPP-A resistant insulin-like growth factor binding protein 4 (dBP4) inhibits angiogenesis and metastasis in a murine model of breast cancer.

Authors:  Y E Smith; S Toomey; S Napoletano; G Kirwan; C Schadow; A J Chubb; J H Mikkelsen; C Oxvig; J H Harmey
Journal:  BMC Cancer       Date:  2018-10-22       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.